-
2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-1,3-benzodiazole
-
ChemBase ID:
154750
-
Molecular Formular:
C19H21F3N6
-
Molecular Mass:
390.4054496
-
Monoisotopic Mass:
390.17797936
-
SMILES and InChIs
SMILES:
CCc1cncnc1N1CCN(CC1)Cc1[nH]c2ccc(cc2n1)C(F)(F)F
Canonical SMILES:
CCc1cncnc1N1CCN(CC1)Cc1nc2c([nH]1)ccc(c2)C(F)(F)F
InChI:
InChI=1S/C19H21F3N6/c1-2-13-10-23-12-24-18(13)28-7-5-27(6-8-28)11-17-25-15-4-3-14(19(20,21)22)9-16(15)26-17/h3-4,9-10,12H,2,5-8,11H2,1H3,(H,25,26)
InChIKey:
FBLPQCAQRNSVHB-UHFFFAOYSA-N
-
Cite this record
CBID:154750 http://www.chembase.cn/molecule-154750.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-1,3-benzodiazole
|
|
|
IUPAC Traditional name
|
2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-1,3-benzodiazole
|
|
|
Synonyms
|
2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-1H-benzimidazole
|
PF 4708671
|
PF-4708671
|
2-((4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-5-(trifluoromethyl)-1H-benzo[d]imidazole
|
PF-4708671
|
PF-04708671
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Acceptors
|
5
|
H Donor
|
1
|
LogD (pH = 5.5)
|
2.8925872
|
LogD (pH = 7.4)
|
3.5038738
|
Log P
|
3.5190928
|
Molar Refractivity
|
101.9805 cm3
|
Polarizability
|
38.17423 Å3
|
Polar Surface Area
|
60.94 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
Acid pKa
|
11.393908
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
PZ0143
|
Legal Information Sold for research purposes under agreement from Pfizer Inc. Biochem/physiol Actions PF-4708671 is a selective p70 ribosomal S6 kinase (S6K1) inhibitor. PF-4708671 inhibits S6K1 with a Ki of 20 nM and IC50 of 160 nM, while having no effect on the closely related RSK and MSK kinases. |
Toronto Research Chemicals -
P294010
|
PF-4708671 is a highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). PF-4708671 inhibits S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect on highly related RSK (p90 ribosomal S |
PATENTS
PATENTS
PubChem Patent
Google Patent